Fabricante do Ozempic estuda menor dose oral de semaglutida capaz de ajudar na perda de peso

Pursuing patient options, Novo kicks off trial testing smaller doses of Wegovy pill

Just eight months after it introduced its oral version of semaglutide for obesity, also known as the Wegovy pill, Novo Nordisk is testing the GLP-1 in smaller doses in the late-stage